25 of the Best Oncologists Near Me

Julie R. Brahmer, M.D., M.Sc. is the Director of the Thoracic Oncology Program, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Marilyn Meyerhoff Professor in Thoracic Oncology. She also directs the Kimmel Cancer Center on the Johns Hopkins Bayview campus and is co-principal investigator on Johns Hopkins' National Clinical Trials Network. Dr. Brahmer received her undergraduate degree in Chemistry and Philosophy in 1989 from the Creighton University in Omaha, Nebraska and went on to receive her medical degree from the University of Nebraska Medical Center College of Medicine in 1993. Completing her internship and residency in Internal Medicine at the University of Utah, Dr. Brahmer later became the Chief Medical Resident until moving to Baltimore to complete her fellowship in Medical Oncology at the Kimmel Cancer Center at Johns Hopkins. Dr. Brahmer is an active clinical leader in the treatment of lung cancer and mesothelioma. She leads the organization of the multidisciplinary thoracic malignancy conference whose members meet weekly to discuss thoracic malignancy cases that need a multidisciplinary review/approach. Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer's research interests include leading early phase immunotherapy trials of anti-PD-1 antibodies, international phase III studies of immunotherapies in lung cancer and investigator-initiated trials evaluating epigenetic therapies in combination with immunotherapies. She is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is one of the founding Board members for the National Lung Cancer Partnership (formerly Women Against Lung Cancer). Within the National Lung Cancer Partnership, she currently serves as a member and the Chairman of the Scientific Executive Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. Dr. Brahmer is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Brahmer is board certified in American Board Of Internal Medicine. Dr. Brahmer is currently accepting new patients.

Mark J. Levis, M.D., Ph.D., professor of oncology, medicine and pharmacology in the Division of Hematologic Malignancies at the Johns Hopkins University School of Medicine, co-directs the Hematologic Malignancies and Bone Marrow Transplantation Program and directs the Adult Leukemia Service at the Johns Hopkins Sidney Kimmel Cancer Center. In addition to his role within the Kimmel Cancer Center, he serves on the faculty for the Johns Hopkins Graduate Training Program in Cellular and Molecular Medicine, a Ph.D. program that prepares scientists to conduct laboratory research at the cellular and molecular level that is designed to have a direct impact on the understanding of human diseases. Dr. Levis has expertise in acute and chronic myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes. Dr. Levis received his medical degree at the University of California, San Francisco School of Medicine, where he also earned his Ph.D. in Biochemistry. He completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology. Dr. Levis is a member of the American Society of Hematology, the American Society of Clinical Oncology and the European Hematology Association. He is an ad hoc member of the Oncology Drug Advisory Committee, as well as an ad hoc manuscript referee for peer-reviewed journals such as New England Journal of Medicine; Leukemia; Clinical Cancer Research; and The American Journal of Hematology. Dr. Levis has earned numerous awards, such as the Daniel Nathans Research Award from Johns Hopkins University, the Osler Housestaff Teaching Award, the Director's Teaching Award in Clinical Science, and the Advanced Clinical Research Award from the American Society of Clinical Oncology. Dr. Levis’ laboratory research focuses on the development of molecularly-targeted therapies for leukemia. He is actively involved in the pre-clinical and clinical development of small molecule inhibitors of protein kinases, including FLT3. The research involves studying the biochemical effects of these inhibitors on samples taken from leukemia patients, with the broad goal of identifying and validating novel molecular therapeutic targets in these hematopoietic malignancies. While Dr. Levis plays a key role in the pre-clinical development of these therapies, he is particularly interested in translating this research to the bedside of his patients by using correlative studies to incorporate these novel therapies into existing treatments. In addition to his work in both the clinic and the laboratory, Dr. Levis has also conducted talks, mentorship and teaching lectures, and published extensively in the top journals in his field, including Leukemia; Blood; and the New England Journal of Medicine. Dr. Levis is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Levis is currently accepting new patients.

Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.

Jubilee Brown is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Brown is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Endoscopy, and Tubal Ligation. Dr. Brown is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology, Gynecologic Oncology. Dr. Brown is currently accepting new patients.

Jane Meisel is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Meisel is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, and Ovarian Cancer. Dr. Meisel is board certified in American Board Of Internal Medicine, 2014. Dr. Meisel is currently accepting new patients.

Barry Rosen is an Oncologist and a Surgical Oncologist practicing medicine in Dearborn, Michigan. Dr. Rosen is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Salpingo-Oophorectomy, and Bladder Reconstruction. Dr. Rosen is board certified in Royal College Of Physicians And Surgeons Of Canada. Dr. Rosen is currently accepting new patients.

Shira Dinner is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Dinner is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dinner is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Dinner is currently accepting new patients.

Ursa Brown-Glaberman is an Oncologist practicing medicine in Los Alamos, New Mexico. Dr. Brown-Glaberman is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Brown-Glaberman is board certified in American Board Of Internal Medicine. Dr. Brown-Glaberman is currently accepting new patients.

My research interests include: CSF-1 and its role in neoplastic progression and metastasis of ovarian cancer; the role of RNA binding proteins and miRNAs in regulation of CSF-1 expression. Androgens and neoplastic transformation of normal ovarian surface epithelium. and the c-fms proto-oncogene and breast cancer invasiveness and bone metastasis; mechanism of regulation of c-fms expression novel c-fms RNA binding proteins and miRNAs. Dr. Chambers is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Salpingo-Oophorectomy, and Bladder Reconstruction. Dr. Chambers is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology. Dr. Chambers is currently accepting new patients.

David Einstein is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Einstein is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Prostatectomy. Dr. Einstein is board certified in American Board Of Internal Medicine. Dr. Einstein is currently accepting new patients.

Kevin Holcomb is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Holcomb is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Salpingo-Oophorectomy, and Lymphadenectomy. Dr. Holcomb is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology. Dr. Holcomb is currently accepting new patients.

Luis A. Rojas, MD, provides gynecologic oncology services at Avera Medical Group Gynecologic Oncology in Sioux Falls, SD. Dr. Rojas is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Malignant Mixed Mullerian Tumor, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, and Hernia Surgery. Dr. Rojas is board certified in American Board Of Obstetrics And Gynecology; Board Certified In Gynecologic Oncology. Dr. Rojas is currently accepting new patients.

Robert Randolph is an Oncologist practicing medicine in Chico, California. Dr. Randolph is highly rated in 63 conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Breast Cancer.

Asad Sheikh, MD, a board-certified medical oncologist, serves as the director of oncology at Orlando Health Cancer Institute at South Seminole Hospital. Dr. Sheikh joined Orlando Health Cancer Institute from the Medical College of Georgia where he served as chief fellow of the hematology/oncology fellowship program. He is board certified in hematology, medical oncology and internal medicine. After joining Orlando Health Cancer Institute in Lake Mary, Dr. Sheikh singlehandedly developed a comprehensive community medical oncology and hematology program including inpatient and outpatient oncology clinics as well as an infusion center serving Seminole county.Dr. Sheikh earned his medical degree from Allama Iqbal Medical College in Pakistan and completed an internship for the Department of Surgery and Medicine at Services Hospital in Pakistan the following year.He worked at the Radiotherapy Clinics of Georgia in Decatur, GA, where he was a clinical research physician and awarded permanent residency in the United States under the special category of Outstanding Professor/Researcher in the Field of Cancer. Dr. Sheikh went on to complete his internship and residency in internal medicine at the University of Florida in Gainesville, FL. Dr. Sheikh has a license to practice medicine in California, Florida, Georgia and Pakistan. He is a member of several organizations, including the American Society of Clinical Oncology, the American Society of Hematology and Oncology and the Patient Welfare Society.Dr. Sheikh has published several studies for the American Society of Clinical Oncology and presented the second largest data trial published in the U.S. on breast cancer in the community setting.Dr. Sheikh also designed, developed and maintained MS Access and SQL databases for cancer patients. His research has been featured in national and international scientific assemblies such as the American Society of Clinical Oncology, the American Society for Radiation Oncology, the British Oncologic Association and the San Antonio Breast Cancer Symposium. Dr. Sheikh is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Sheikh is board certified in American Board Of Osteopathic IM - Medical Onc and American Board Of Internal Medicine. Dr. Sheikh is currently accepting new patients.

Alexander Olawaiye, MD, is a professor of gynecologic oncology at the University of Pittsburgh and Magee-Womens Hospital of UPMC. He specializes in gynecologic malignancies, as well as endometrial, ovarian, cervical, vulvar, and vaginal cancers.Dr. Olawaiye is board-certified in obstetrics and gynecology as well as gynecologic oncology. He completed an undergraduate degree at the University of Ibadan, Nigeria, and received a medical degree from the Royal College of Obstetricians and Gynecologists in London, UK. Dr. Olawaiye completed a residency at the State University of New York at Buffalo, and a gynecologic oncology fellowship at Harvard Medical School.Dr. Olawaiye is a member of professional organizations such as the Society for Gynecologic Oncologists, American Society of Gynecologic Oncologists and the American Joint Committee on Cancer. He maintains a research interest in translational and clinical research for endometrial, ovarian, cervical, and vulvar cancers. Dr. Olawaiye is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Vulvectomy, and Salpingo-Oophorectomy. Dr. Olawaiye is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Olawaiye is currently accepting new patients.

Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman-Censits is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Bladder Reconstruction. Dr. Hoffman-Censits is board certified in American Board Of Internal Medicine. Dr. Hoffman-Censits is currently accepting new patients.

Craig Hofmeister is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Hofmeister is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hofmeister is board certified in American Board Of Internal Medicine, 2005. Dr. Hofmeister is currently accepting new patients.

Dr. Sukumvanich is a specialized surgeon and gynecologic oncologist, specializing in the treatment of gynecologic and breast cancers. He serves as an assistant professor in the School of Medicine, and his research centers on the genetic causes of ovarian and breast cancers, and also cancer informatics (the science of analyzing large amounts of information). Dr. Sukumvanich is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Vulvectomy, and Lymphadenectomy. Dr. Sukumvanich is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Sukumvanich is currently accepting new patients.

Kathryn Mileham is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Mileham is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Mileham is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Mileham is currently accepting new patients.

Haider Mahdi is an Oncologist practicing medicine in West Bloomfield, Michigan. Dr. Mahdi is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Lymphadenectomy, and Endoscopy. Dr. Mahdi is board certified in American Board Of Obstetrics And Gynecology. Dr. Mahdi is currently accepting new patients.

David Lawson is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 52 years. Dr. Lawson is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Brain Tumor, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor. Dr. Lawson is board certified in American Board Of Internal Medicine, 1979. Dr. Lawson is currently accepting new patients.

Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah.  Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium).  He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy.  Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant.  For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia.  This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion.  His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure.  Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process.  To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Aplastic Anemia, and Bone Marrow Transplant. Dr. Pulsipher is board certified in American Board Of Pediatrics. Dr. Pulsipher is currently accepting new patients.

Gerburg Wulf is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Wulf is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT). Dr. Wulf is board certified in American Board Of Internal Medicine. Dr. Wulf is currently accepting new patients.

David Vanderweele is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Vanderweele is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Vanderweele is board certified in American Board Of Internal Medicine - Medical Oncology (Certified). Dr. Vanderweele is currently accepting new patients.

Don Dizon is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Dizon is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Breast Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, and Salpingo-Oophorectomy. Dr. Dizon is currently accepting new patients.